C12Q 2537/165
Mathematical modelling
Official title: Mathematical modelling, e.g. logarithm, ratio
C12Q2537/165 (Mathematical modelling) appears on 67 US grants and 109 published applications in this corpus.
Search patents in C12Q- Granted patents
- 67
- Published applications
- 109
- Assignees
- 78
- Inventors
- 237
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 4 |
| 2014 | 4 | 3 |
| 2015 | 1 | 5 |
| 2016 | 2 | 4 |
| 2017 | 1 | 7 |
| 2018 | 3 | 14 |
| 2019 | 3 | 16 |
| 2020 | 7 | 14 |
| 2021 | 13 | 14 |
| 2022 | 4 | 4 |
| 2023 | 6 | 3 |
| 2024 | 7 | 5 |
| 2025 | 4 | 6 |
| 2026 | 9 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Detection and prediction of infectious disease6 Oct 2026US 12,753,448 B2Karius, Inc.
- Identification and use of circulating nucleic acid tumor markers15 Sep 2026US 12,735,749 B2The Board of Trustees of the Leland Stanford Junior University
- Identification and use of circulating nucleic acid tumor markers15 Sep 2026US 12,735,750 B2The Board of Trustees of the Leland Stanford Junior University
- Systems and methods to detect rare mutations and copy number variation15 Sep 2026US 12,735,751 B2Guardant Health, Inc.
- Methods and systems for determining proportions of distinct cell subsets28 Jul 2026US 12,692,551 B2The Board of Trustees of the Leland Stanford Junior University
- Method and kits for a transcriptomic signature with empirically derived algorithm correlated to the presence of acute rejection on kidney biopsy in transplant recipient blood25 Jun 2026US 2026/0176695 A1Verici Dx Limited
- Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage7 May 2026US 2026/0125769 A1Guardant Health, Inc.
- Multiallelic Genotyping Of Single Nucleotide Polymorphisms And Indels30 Apr 2026US 2026/0117294 A1Affymetrix, Inc.
- Microrna diagnostic assay for chronic kidney disease20 Nov 2025US 2025/0354214 A1MI:RNA Ltd.
- Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage7 Aug 2025US 2025/0250644 A1Guardant Health, Inc.
Most cited
By later US patents
- Methods for non-invasive prenatal ploidy calling150US 8,825,412 B2Natera, Inc. · 2014
- Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale21US 8,877,442 B2The Board of Trustees of the Leland Stanford Junior University · 2014
- Method for detecting a genetic variant18US 10,640,819 B2Cancer Research Technology Limited · 2020
- Baselining amplification data13US 7,720,611 B2Bio-Rad Laboratories, Inc. · 2010
- Methods for non-invasive prenatal ploidy calling10US 11,306,357 B2Natera, Inc. · 2022